abstract |
The present invention relates to a pharmaceutical formulation comprising an androstane series anti-inflammatory glucocorticoid compound and levocabastine, an H 1 antagonist / anti-allergic agent. The invention also relates to the use of this formulation for therapeutic purposes, in particular to treat inflammatory and allergic conditions, in particular rhinitis. [Selection figure] None |